Citation Impact
Citing Papers
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis
2010
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Iron deficiency: still under-diagnosed?
2015
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Hepatitis C virus infection acquired in childhood
2007
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study
2018
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
“Rescue” regimens after Helicobacter pylori treatment failure
2008
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
2014
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
The long‐term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis
2002
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Functional Gastroduodenal Disorders
2006 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Clinical trial: levofloxacin‐based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection
2007
Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron‐deficiency anaemia presentation
2006
Helicobacter pylori Infection and Iron Stores: A Systematic Review and Meta‐analysis
2008
Gastric mucosa: long-term outcome after cure ofHelicobacter pylori infection
2002
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
2009
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
2015
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Efficacy of tailoredHelicobacter pylorieradication therapy based on antibiotic susceptibility andCYP2C19genotype
2014
Enhancing Compliance Not A Prerequisite for Effective Eradication of Helicobacter Pylori : The Help Study
1999
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007
Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection
2016
Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis. CME
2006
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
The Oslo definitions for coeliac disease and related terms
2012 Standout
Effect ofMDR1C3435T polymorphism on cure rates ofHelicobacter pyloriinfection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation toCYP 2C19 genotypes and 23S rRNA genotypes ofH. pylori
2007
Antimicrobial treatment of H. pylori infection-a pooled efficacy analysis of eradication therapies
2002
Hepatocellular carcinoma
2021 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
The interplay between the intestinal microbiota and the brain
2012 Standout
Helicobacter pylori impairs iron absorption in infected individuals
2004
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium‐dependent potassium channel opening
2009
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Thyroxine in Goiter, Helicobacter pylori Infection, and Chronic Gastritis
2006
Iron-Deficiency Anemia and Helicobacter pylori Infection: A Review of the Evidence
2005
Levofloxacin- versus metronidazole-based rescue therapy for infection in Japan
2005
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance
2007
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Clinical effects of Helicobacter pylori outside the stomach
2013
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection
2005
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group
2014
Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure
2005
Characterization of Microbiota in Children with Chronic Functional Constipation
2016
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Rabeprazole: the role of proton pump inhibitors inHelicobacter pylorieradication
2005
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
2009
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Hepatitis B virus infection
2018
Helicobacter pyloriInfection
2002 Standout
The Impact of Helicobacter pylori Eradication on Peptic Ulcer Healing
1998
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
2002
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
High efficacy of 1‐week doxycycline‐ and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection
2004
Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
2006
Pharmacogenomics-based Tailored Versus Standard Therapeutic Regimen for Eradication of H. pylori
2007
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients
2007
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Systematic review: Heliocobacter pylori infection and impaired drug absorption
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Interventions to Enhance Patient Adherence to Medication Prescriptions
2002 Standout
Helicobacter pylori first‐line treatment and rescue options in patients allergic to penicillin
2005
Hypothalamic Hormones and Cancer
2001 Nobel
Treatment with lamivudine and entecavir in severe acute hepatitis B
2016
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Non–Gastrointestinal Tract Associations of Helicobacter pylori Infection
1999
The Eradication of Helicobacter pylori is Affected by Body Mass Index (BMI)
2008
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Guidelines for the management of iron deficiency anaemia
2011
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Hepatocellular Carcinoma
2019 Standout
Basis for the Management of Drug-Resistant Helicobacter pylori Infection
2004
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Probiotic Bacteria Influence the Composition and Function of the Intestinal Microbiota
2008
Cancer and the gut microbiota: An unexpected link
2015
Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
2004
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL‐cell hyperplasia
2000
Interventions for enhancing medication adherence
2008 Standout
A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic Effect
2018
The role of hepatic resection in the treatment of hepatocellular cancer
2015
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials
2010
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis.
2010
Interventions for enhancing medication adherence
2014 Standout
Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
2015
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Rapid Detection of Point Mutations in the gyrA Gene of Helicobacter pylori Conferring Resistance to Ciprofloxacin by a Fluorescence Resonance Energy Transfer-Based Real-Time PCR Approach
2004
Autoimmune Gastropathy in Type 1 Diabetic Patients With Parietal Cell Antibodies
2003
Guidelines in the management of Helicobacter pylori infection in Japan
2003
Iron-Deficiency Anemia
2015 Standout
Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects.
2005
Forging a field: the golden age of iron biology
2008
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
2015
The impact of Helicobacter pylori eradication on peptic ulcer healing
1998
2007
How I treat unexplained refractory iron deficiency anemia
2013
Works of Massimo Marignani being referenced
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours
1998
Zollinger‐Ellison syndrome and antral G‐cell hyperfunction in patients with resistant duodenal ulcer disease
1994
Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: A case report
2011
Effect of Acute Mucosal Exposure to Lactobacillus rhamnosus GG on Human Colonic Smooth Muscle Cells
2008
High Prevalence of Atrophic Body Gastritis in Patients With Unexplained Microcytic and Macrocytic Anemia
1999
Postbiotic Activities of Lactobacilli-derived Factors
2014
Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification
1997
Atrophic Body Gastritis: Distinct Features Associated with Helicobacter pylori Infection
1997
A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication
2003
Patients with hematological malignancies and serological signs of prior resolved hepatitis B
2012
Does an ‘autoimmune’ profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey
2004
Reversal of Long-Standing Iron Deficiency Anaemia after Eradication ofHelicobacter pyloriInfection
1997
Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies
2014
Probiotics and the incidence of colorectal cancer: when evidence is not evident
2006
Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
1997
Evidence that H. pylori eradication is not always associated with peptic ulcer healing
1995
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study
2017
A Prospective Study of Gastric Carcinoids and Enterochromaffin-Like Cell Changes in Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: Identification of Risk Factors
2008
Duodenal ulcer and Helicobacter pylori: Relapse and recurrence in a long-term study
1998
High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia A prospective screening study
1999
Reversal of Iron Deficiency Anemia after Helicobacter pylori Eradication in Patients with Asymptomatic Gastritis
1999
Adherence to American Association for the Study of Liver Diseases Guidelines for the Management of Hepatocellular Carcinoma: Results of an Italian Field Practice Multicenter Study
2013
Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth.
1996
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: a multicenter cohort study
2017
Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association.
1999
Hepatitis B in patients with hematological diseases: An update
2017